Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.

Dworkin RH, Allen R, Kopko S, Lu Y, Turk DC, Burke LB, Desjardins P, Etropolski M, Hewitt DJ, Jayawardena S, Lin AH, Malamut R, Michel D, Ottinger J, Peloso P, Pucino F, Rappaport BA, Skljarevski V, St Peter D, Timinski S, West CR, Wilson HD.

Pain. 2013 Jan;154(1):11-4. doi: 10.1016/j.pain.2012.10.014. Epub 2012 Oct 26. Review. No abstract available.

PMID:
23218970
3.

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.

Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D, Smith C, Ginsberg R, Eldridge J, Duerr A, Fast P, Haynes BF; AIDS Vaccine Evaluation Group.

PLoS One. 2010 Aug 10;5(8):e11995. doi: 10.1371/journal.pone.0011995.

4.

Modeling flow cytometry data for cancer vaccine immune monitoring.

Frelinger J, Ottinger J, Gouttefangeas C, Chan C.

Cancer Immunol Immunother. 2010 Sep;59(9):1435-41. doi: 10.1007/s00262-010-0883-4. Epub 2010 Jun 19. Review.

5.

Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).

Murdoch DM, Suchard MS, Venter WD, Mhlangu P, Ottinger JS, Feldman C, Van Rie A, Glencross DK, Stevens WS, Weinhold KJ.

AIDS Res Ther. 2009 Jul 16;6:16. doi: 10.1186/1742-6405-6-16.

6.

The effect of beta-blocker dosing strategy on regulation of perioperative heart rate and clinical outcomes in patients undergoing vascular surgery: a randomized comparison.

Cesanek P, Schwann N, Wilson E, Urffer S, Maksimik C, Nabhan S, Ottinger J, Astbury J, Xiang Y, Matsumura ME.

Ann Vasc Surg. 2008 Sep;22(5):643-8. doi: 10.1016/j.avsg.2008.04.003. Epub 2008 Jun 17.

PMID:
18562162
7.

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.

Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody MA, Ferrari G, Weinhold KJ, Miller SE, Reich CF 3rd, Qin L, Self SG, Shaw GM, Denny TN, Jones LE, Pisetsky DS, Haynes BF.

J Virol. 2008 Aug;82(15):7700-10. doi: 10.1128/JVI.00605-08. Epub 2008 May 28.

8.

Statistical mixture modeling for cell subtype identification in flow cytometry.

Chan C, Feng F, Ottinger J, Foster D, West M, Kepler TB.

Cytometry A. 2008 Aug;73(8):693-701. doi: 10.1002/cyto.a.20583.

9.

Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.

McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Oxford C, Evans TG, Asmuth DM.

Cytometry A. 2008 May;73(5):400-10. doi: 10.1002/cyto.a.20555.

10.

Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.

McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Li J, Beckett L, Shacklett BL, Evans TG, Asmuth DM.

Cytometry A. 2008 May;73(5):411-20. doi: 10.1002/cyto.a.20556.

11.

Standardization of cytokine flow cytometry assays.

Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, Landry C, Hayes P, Birungi J, Anzala O, Garcia M, Harari A, Frank I, Baydo R, Baker M, Holbrook J, Ottinger J, Lamoreaux L, Epling CL, Sinclair E, Suni MA, Punt K, Calarota S, El-Bahi S, Alter G, Maila H, Kuta E, Cox J, Gray C, Altfeld M, Nougarede N, Boyer J, Tussey L, Tobery T, Bredt B, Roederer M, Koup R, Maino VC, Weinhold K, Pantaleo G, Gilmour J, Horton H, Sekaly RP.

BMC Immunol. 2005 Jun 24;6:13.

12.

Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.

Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.

J Immunol. 2004 Aug 1;173(3):2126-33.

13.

Octreotide for persistent chylothorax in a pediatric patient.

Ottinger JG.

Ann Pharmacother. 2002 Jun;36(6):1106-7. No abstract available.

PMID:
12058708
14.

Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.

Bartlett JA, Miralles GD, Sevin AD, Silberman M, Pruitt SK, Ottinger J, Gryszowska V, Fiscus SA, Bucy RP; ACTG 380 Study Team.

AIDS Res Hum Retroviruses. 2002 May 20;18(8):535-43.

PMID:
12036483
15.

Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.

Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, St Clair M, McKinney RE.

Pediatr Infect Dis J. 2001 Oct;20(10):941-6.

PMID:
11642627
16.

Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression.

Demarest JF, Jack N, Cleghorn FR, Greenberg ML, Hoffman TL, Ottinger JS, Fantry L, Edwards J, O'Brien TR, Cao K, Mahabir B, Blattner WA, Bartholomew C, Weinhold KJ.

AIDS Res Hum Retroviruses. 2001 Sep 20;17(14):1333-44.

PMID:
11602044
17.

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.

Ferrari G, Neal W, Jones A, Olender N, Ottinger J, Ha R, McElrath MJ, Goepfert P, Weinhold KJ.

Immunol Lett. 2001 Nov 1;79(1-2):37-45.

PMID:
11595288
18.

Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.

Wellons MF, Ottinger JS, Weinhold KJ, Gryszowka V, Sanders LL, Edwards LJ, Gooding ME, Thomasch JR, Bartlett JA.

J Infect Dis. 2001 May 15;183(10):1522-5. Epub 2001 Apr 17.

19.

Determination of free levels of phenytoin in human plasma by liquid chromatography/tandem mass spectrometry.

Bardin S, Ottinger JC, Breau AP, O'Shea TJ.

J Pharm Biomed Anal. 2000 Aug 15;23(2-3):573-9.

PMID:
10933551
20.

Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

Markert ML, Hicks CB, Bartlett JA, Harmon JL, Hale LP, Greenberg ML, Ferrari G, Ottinger J, Boeck A, Kloster AL, McLaughlin TM, Bleich KB, Ungerleider RM, Lyerly HK, Wilkinson WE, Rousseau FS, Heath-Chiozzi ME, Leonard JM, Haase AT, Shaw GM, Bucy RP, Douek DC, Koup RA, Haynes BF, Bolognesi DP, Weinhold KJ.

AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):403-13.

PMID:
10772526
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk